❭ Research by medical division ❭ Laboratory Medicine ❭ Dept. of Immunology ❭ Molecular immunology and vaccine development (Braathen) ❭ In the media ❭

In the media

Blog: Vaksinebloggen

Podcast: Vaksinepodden

 
Scroll to top

Home Dept. of Immunology Molecular immunology and vaccine development (Braathen)

  • Group members
  • Publications
  • In the media
  • Funding

Recent publications

Fossum E, Vikse EL, Robertson AH, Wolf AS, Rohringer A, Trogstad L, Mjaaland S, Hungnes O, Bragstad K (2025)
Low Levels of Neutralizing Antibodies Against SARS-CoV-2 KP.3.1.1 and XEC in Serum From Seniors in May 2024
Influenza Other Respir Viruses, 19 (5), e70102
DOI 10.1111/irv.70102, PubMed 40369880

Gopalakrishnan RP, Østrøm MS, Skjeldal FM, Bakke O, Bogen B, Huszthy PC (2024)
B Cells With Complementary B Cell Receptors Can Kill Each Other
Eur J Immunol, 55 (1), e202350890
DOI 10.1002/eji.202350890, PubMed 39520365

Garcia I, Bråte J, Fossum E, Rohringer A, Moen LV, Hungnes O, Fjære O, Zaragkoulias K, Bragstad K (2024)
Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patient
Sci Rep, 14 (1), 25790
DOI 10.1038/s41598-024-75241-3, PubMed 39468221

More publications

Get in touch

Ranveig Braathen
Institute of Immunology, Rikshospitalet, Oslo University Hospital
Sognsvannsveien 20, Section A2. 2nd. floor, Room:  A3.2006, 0372 Oslo, Norway
Phone: + 47 23 07 35 08, Cell: + 47 99732296, Fax: + 47 23 07 35 10
Email: Ranveig.braathen@medisin.uio.no, Ranveig.braathen@rr-research.no, ranvbr@ous-hf.no

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)